164 related articles for article (PubMed ID: 4150175)
1. [5 years' experience with prolonged-action neuroleptics].
Lopez-Ibor Aliño JM; Tabares Pujante J
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
[No Abstract] [Full Text] [Related]
2. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
Salvesen C; Vaksdal K
Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
[No Abstract] [Full Text] [Related]
3. Suicidal risk in the treatment of outpatient schizophrenics with long-acting neuroleptics.
Niturad A; Nicholschi-Oproiu L
Agressologie; 1978; 19(C):145-8. PubMed ID: 35993
[No Abstract] [Full Text] [Related]
4. Twelve years' experience with the total use of depot neuroleptics in a defined population.
Freeman H
Adv Biochem Psychopharmacol; 1980; 24():559-64. PubMed ID: 6105801
[No Abstract] [Full Text] [Related]
5. Eleven years of experience with depot neuroleptics.
Gross H; Kaltenbäck E; Pfolz H
Acta Psychiatr Belg; 1981; 81(2):128-32. PubMed ID: 6117183
[TBL] [Abstract][Full Text] [Related]
6. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
Dursun S
J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
[No Abstract] [Full Text] [Related]
7. The long-term treatment of schizophrenia in the community.
Rollin HR
Practitioner; 1982 Jul; 226(1369):1330-3. PubMed ID: 6125936
[No Abstract] [Full Text] [Related]
8. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
Costentin J
Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
[No Abstract] [Full Text] [Related]
9. Schizophrenia.
Kane JM
N Engl J Med; 1996 Jan; 334(1):34-41. PubMed ID: 7494570
[No Abstract] [Full Text] [Related]
10. New drug development in France and French-speaking countries. Short and long acting neuroleptics.
Deniker P; Ginestet D; Peron-Magnan P
Dis Nerv Syst; 1974 Jul; 35(7 Pt. 2):18-20. PubMed ID: 17894096
[No Abstract] [Full Text] [Related]
11. [Prolonged action neuroleptics and the relationship between physician, patient and family].
Boudef M
Sante Ment Que; 1995; 20(1):233-47. PubMed ID: 7578708
[No Abstract] [Full Text] [Related]
12. Longterm maintenance therapy with depot haloperidol in schizophrenia.
Zbytovský J
Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
[No Abstract] [Full Text] [Related]
13. [Prophylactic efficacy of long-acting vs. short-acting neuroleptics in schizophrenic out-patients (author's transl)].
Tegeler J; Lehmann E; Stockschlaeder M
Nervenarzt; 1980 Nov; 51(11):654-61. PubMed ID: 6109262
[No Abstract] [Full Text] [Related]
14. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
15. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
[No Abstract] [Full Text] [Related]
16. Psychopharmacological treatment of schizophrenia.
Lehmann HE
Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851
[No Abstract] [Full Text] [Related]
17. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
Benoit M; Pon J; Zimmermann MA
Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
[No Abstract] [Full Text] [Related]
18. [Experience with long acting psychopharmaceutics in psychiatric hospitals].
Reimer F
Int Pharmacopsychiatry; 1974; 9(4):245-7. PubMed ID: 4156352
[No Abstract] [Full Text] [Related]
19. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
Jones A
J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
[TBL] [Abstract][Full Text] [Related]
20. [Expert opinion on APAP (Prolonged action atypical antipsychotic agents). Conclusion].
Guelfi JD
Encephale; 2009 Jan; Suppl 3():S123-4. PubMed ID: 19268182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
